Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 1513 to 1562 of 8289 in total 
Value Type: Measured
Network Comparison Type: Divided
Filtered: 1

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Interaction Map\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
757\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
signal recognition particle 68 kda protein (srp68). [source:swissprot;acc:q9uhb9]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5622.89\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6260.02\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.11331\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
surfeit locus protein 1. [source:swissprot;acc:q15526]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7988.86\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8325.55\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04214\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
758\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dna polymerase epsilon subunit b (ec 2.7.7.7) (dna polymerase ii subunit b). [source:swissprot;acc:p56282]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3760.3\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4185.82\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.11316\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
growth factor receptor-bound protein 2 (grb2 adapter protein) (sh2/sh3 adapter grb2) (ash protein). [source:swissprot;acc:p29354]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7862.29\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8193.26\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0421\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
759\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
6-phosphofructokinase, type c (ec 2.7.1.11) (phosphofructokinase 1) (phosphohexokinase) (phosphofructo-1-kinase isozyme c) (pfk-c) (6-phosphofructokinase, platelet type). [source:swissprot;acc:q01813]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4254.62\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4736.03\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.11315\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
cytochrome p450 3a43 (ec 1.14.14.1). [source:swissprot;acc:q9hb55]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8087.27\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8427.25\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04204\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
760\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
atpase, h+ transporting, lysosomal 38kda, v0 subunit d isoform 2. [source:refseq;acc:nm\_152565]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5870.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6533.39\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.11298\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
odd-skipped related 1; odz (odd oz/ten-m) related 1. [source:refseq;acc:nm\_145260]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
7152.13\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7452.64\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04202\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
761\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
electron transfer flavoprotein alpha-subunit, mitochondrial precursor (alpha-etf). [source:swissprot;acc:p13804]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
8831.38\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9202.43\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04201\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
translation initiation factor if-2. [source:swissprot;acc:o60841]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
5811.51\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6467.62\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.1129\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
762\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
pms1 protein homolog 2 (dna mismatch repair protein pms2). [source:swissprot;acc:p54278]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
6231.31\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6933.9\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.11275\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
suppressor of actin mutations 2-like isoform b; dj1033b10.5. [source:refseq;acc:nm\_022553]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8056.9\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8395.02\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04197\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
763\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
6-phosphofructokinase, muscle type (ec 2.7.1.11) (phosphofructokinase 1) (phosphohexokinase) (phosphofructo-1-kinase isozyme a) (pfk-a) (phosphofructokinase-m). [source:swissprot;acc:p08237]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4250.54\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4729.67\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.11272\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
cytochrome p450 3a5 (ec 1.14.14.1) (cypiiia5) (p450-pcn3). [source:swissprot;acc:p20815]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8087.04\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8426.3\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04195\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
764\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
6-phosphofructokinase, liver type (ec 2.7.1.11) (phosphofructokinase 1) (phosphohexokinase) (phosphofructo-1-kinase isozyme b) (pfk-b). [source:swissprot;acc:p17858]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4250.18\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4729.12\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.11269\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
cytochrome p450 3a7 (ec 1.14.14.1) (cypiiia7) (p450-hfla). [source:swissprot;acc:p24462]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
8084.46\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8423.24\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04191\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
765\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
copper-transporting atpase 1 (ec 3.6.3.4) (copper pump 1) (menkes disease-associated protein). [source:swissprot;acc:q04656]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
8631.91\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8993.16\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04185\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
polymerase (dna directed) sigma; topoisomerase-related function protein 4-1; polymerase (dna-directed) sigma. [source:refseq;acc:nm\_006999]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4726.38\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5258.95\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.11268\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
766\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cytochrome oxidase biogenesis protein oxa1, mitochondrial precursor (oxa1-like protein) (oxa1hs). [source:swissprot;acc:q15070]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7591.4\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7909.08\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04185\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
ubiquitin-conjugating enzyme e2 variant 1 isoform b; dna-binding protein. [source:refseq;acc:nm\_003349]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6691.93\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7445.09\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.11255\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
767\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
intersectin 2 (sh3 domain-containing protein 1b) (sh3p18) (sh3p18-like wasp associated protein). [source:swissprot;acc:q9nzm3]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
10504.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
10082.3\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04185\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
utp--glucose-1-phosphate uridylyltransferase 2 (ec 2.7.7.9) (udp- glucose pyrophosphorylase 2) (udpgp 2) (ugpase 2). [source:swissprot;acc:q16851]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6691.21\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7444.22\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.11254\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
768\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
synaptic vesicle protein 2b homolog. [source:refseq;acc:nm\_014848]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8135.44\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8475.48\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0418\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
ubiquitin-conjugating enzyme e2 variant 2; 1 alpha,25-dihydroxyvitamin d3-inducible; enterocyte differentiation promoting factor; methyl methanesulfonate sensitive 2, s. cerevisiae, homolog of. [source:refseq;acc:nm\_003350]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6690.44\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7443.29\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.11253\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
769\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
splicing factor, arginine/serine-rich 7 (splicing factor 9g8). [source:swissprot;acc:q16629]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7730.27\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8053.27\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04178\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
vacuolar atp synthase subunit f (ec 3.6.3.14) (v-atpase f subunit) (vacuolar proton pump f subunit) (v-atpase 14 kda subunit). [source:swissprot;acc:q16864]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5873.77\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6532.44\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.11214\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
770\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
u1 small nuclear ribonucleoprotein 70 kda (u1 snrnp 70 kda) (snrnp70) (u1-70k). [source:swissprot;acc:p08621]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7730.27\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8053.27\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04178\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
vacuolar atp synthase subunit g 2 (ec 3.6.3.14) (v-atpase g subunit 2) (vacuolar proton pump g subunit 2) (v-atpase 13 kda subunit 2). [source:swissprot;acc:o95670]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5874.74\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
6533.34\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.11211\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
771\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
apoptosis inhibitor 5; fibroblast growth factor 2-interacting factor 2; api5-like 1. [source:refseq;acc:nm\_006595]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
cytochrome p450 3a4 (ec 1.14.13.67) (quinine 3-monooxygenase) (cypiiia4) (nifedipine oxidase) (nf-25) (p450-pcn1). [source:swissprot;acc:p08684]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8081.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8418.72\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04177\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
772\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
sec13-related protein. [source:swissprot;acc:p55735]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5874.76\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6533.36\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.11211\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
zinc finger protein 183. [source:swissprot;acc:o15541]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
7534.02\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7848.32\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.04172\vspace{3pt}}}\\\cline{1-2}\cline{4-5}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
773\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
tensin. [source:refseq;acc:nm\_022648]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
7319.93\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7625.29\vspace{3pt}}&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
vacuolar atp synthase subunit g 3 (ec 3.6.3.14) (v-atpase g subunit 3) (vacuolar proton pump g subunit 3) (v-atpase 13 kda subunit 3). [source:swissprot;acc:q96lb4]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5874.74\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6533.34\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.11211\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
774\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
coagulation factor xiii a chain precursor (ec 2.3.2.13) (protein- glutamine gamma-glutamyltransferase a chain) (transglutaminase a chain). [source:swissprot;acc:p00488]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6886.05\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7173.24\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04171\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
yeast sec31p homolog. [source:refseq;acc:nm\_014933]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5874.76\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6533.36\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.11211\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
775\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
protein-glutamine gamma-glutamyltransferase k (ec 2.3.2.13) (transglutaminase k) (tgase k) (tgk) (tg(k)) (transglutaminase 1) (epidermal tgase). [source:swissprot;acc:p22735]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6886.05\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7173.24\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04171\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
vacuolar atp synthase subunit g 1 (ec 3.6.3.14) (v-atpase g subunit 1) (vacuolar proton pump g subunit 1) (v-atpase 13 kda subunit 1) (vacuolar atp synthase subunit m16). [source:swissprot;acc:o75348]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
5874.74\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6533.33\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.11211\vspace{3pt}}}\\\cline{1-2}\cline{4-5}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
776\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
ganglioside-induced differentiation-associated protein 1-like 1. [source:refseq;acc:nm\_024034]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
5874.76\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6533.36\vspace{3pt}}&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
ornithine decarboxylase (ec 4.1.1.17) (odc). [source:swissprot;acc:p11926]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8380.36\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8729.64\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04168\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
777\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dead (asp-glu-ala-asp) box polypeptide 39 isoform 1; nuclear rna helicase, decd variant of dead box family. [source:refseq;acc:nm\_005804]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5874.74\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6533.34\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.11211\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
synaptic vesicle glycoprotein 2. [source:refseq;acc:nm\_014849]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
8135.08\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8474.03\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.04167\vspace{3pt}}}\\\cline{1-2}\cline{4-5}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
778\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
ornithine decarboxylase antizyme inhibitor. [source:swissprot;acc:o14977]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
8379.93\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8729.12\vspace{3pt}}&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
vacuolar atp synthase subunit b, kidney isoform (ec 3.6.3.14) (v- atpase b1 subunit) (vacuolar proton pump b isoform 1) (endomembrane proton pump 58 kda subunit). [source:swissprot;acc:p15313]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
5874.63\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6533.23\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.11211\vspace{3pt}}}\\\cline{1-2}\cline{4-5}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
779\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
ganglioside-induced differentiation-associated protein 1. [source:refseq;acc:nm\_018972]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
5874.76\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6533.36\vspace{3pt}}&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
ornithine decarboxylase-like protein (ec 4.1.1.17) (odc-paralogue) (odc-p). [source:swissprot;acc:q96a70]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
8379.96\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8729.16\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.04167\vspace{3pt}}}\\\cline{1-2}\cline{4-5}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
780\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
calcineurin b subunit isoform 1 (protein phosphatase 2b regulatory subunit 1) (protein phosphatase 3 regulatory subunit b alpha isoform 1). [source:swissprot;acc:p06705]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
7325.81\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7631.04\vspace{3pt}}&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
vacuolar atp synthase subunit d (ec 3.6.3.14) (v-atpase d subunit) (vacuolar proton pump d subunit) (v-atpase 28 kda accessory protein). [source:swissprot;acc:q9y5k8]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5874.76\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
6533.36\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.11211\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
781\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
secretory pathway component sec31b-1. [source:refseq;acc:nm\_015490]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
vav proto-oncogene. [source:swissprot;acc:p15498]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8109.84\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8447.62\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04165\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/